Suppr超能文献

肾上腺髓质素通过一种涉及降钙素基因相关肽受体的机制抑制大鼠进食。

Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors.

作者信息

Taylor G M, Meeran K, O'Shea D, Smith D M, Ghatei M A, Bloom S R

机构信息

Division of Endocrinology and Metabolic Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.

出版信息

Endocrinology. 1996 Aug;137(8):3260-4. doi: 10.1210/endo.137.8.8754748.

Abstract

The central effect of adrenomedullin on feeding was investigated in fasted rats. After intracerebroventricular administration, adrenomedullin decreased 2-h food intake in a dose-dependent manner. A dose of 1.7 nmol adrenomedullin decreased 2-h food intake by 57%. Adrenomedullin shares sequence homology with calcitonin gene-related peptide (CGRP), a central anorectic agent, and binding sites for both are present in the hypothalamus. Adrenomedullin competed for [125I]adrenomedullin- and [125I]CGRP-binding sites in hypothalamic membranes. The Kd for the [125I]adrenomedullin-binding site was 0.54 +/- 0.07 nM, with a binding capacity of 214 +/- 27 fmol/mg membrane protein (n = 3). CGRP and the CGRP receptor antagonist CGRP-(8-37) at concentrations up to 1 microM did not compete at these sites. The Kd for the CGRP-binding site was 0.10 +/- 0.02 nM, with a binding capacity of 250 +/- 31 fmol/mg, and the Ki values for adrenomedullin and CGRP-(8-37) were 4.6 +/- 2.1 and 4.0 +/- 1.6 nM, respectively (n = 3). Thus, adrenomedullin showed high affinity binding at both adrenomedullin- and CGRP-binding sites. To establish whether adrenomedullin reduces feeding via CGRP receptors, we coadministered adrenomedullin (1.7 nmol) and CGRP-(8-37) (30 nmol). The reduction in 2-h food intake induced by adrenomedullin was 50% inhibited by CGRP-(8-37). These results show that adrenomedullin decreases food intake in the rat, and this effect is mediated at least in part via CGRP receptors.

摘要

在禁食大鼠中研究了肾上腺髓质素对进食的中枢作用。脑室内给药后,肾上腺髓质素以剂量依赖性方式减少2小时食物摄入量。1.7 nmol剂量的肾上腺髓质素使2小时食物摄入量减少了57%。肾上腺髓质素与降钙素基因相关肽(CGRP,一种中枢性食欲抑制剂)具有序列同源性,且二者的结合位点均存在于下丘脑。肾上腺髓质素可竞争下丘脑膜中[125I]肾上腺髓质素和[125I]CGRP的结合位点。[125I]肾上腺髓质素结合位点的解离常数(Kd)为0.54±0.07 nM,结合容量为214±27 fmol/mg膜蛋白(n = 3)。浓度高达1μM的CGRP和CGRP受体拮抗剂CGRP-(8 - 37)在这些位点不产生竞争。CGRP结合位点的Kd为0.10±0.02 nM,结合容量为250±31 fmol/mg,肾上腺髓质素和CGRP-(8 - 37)的抑制常数(Ki)分别为4.6±2.1和4.0±1.6 nM(n = 3)。因此,肾上腺髓质素在肾上腺髓质素结合位点和CGRP结合位点均表现出高亲和力结合。为确定肾上腺髓质素是否通过CGRP受体减少进食,我们联合给予肾上腺髓质素(1.7 nmol)和CGRP-(8 - 37)(30 nmol)。CGRP-(8 - 37)可抑制肾上腺髓质素诱导的2小时食物摄入量减少的50%。这些结果表明,肾上腺髓质素可减少大鼠的食物摄入量,且这种作用至少部分是通过CGRP受体介导的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验